BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24496100)

  • 1. Dopamine replacement therapy and deep brain stimulation of the subthalamic nuclei induce modulation of emotional processes at different spatial frequencies in Parkinson's disease.
    Mermillod M; Mondillon L; Rieu I; Devaux D; Chambres P; Auxiette C; Dalens H; Coulangeon LM; Jalenques I; Durif F
    J Parkinsons Dis; 2014; 4(1):97-110. PubMed ID: 24496100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined effect of subthalamic nuclei deep brain stimulation and L-dopa increases emotion recognition in Parkinson's disease.
    Mondillon L; Mermillod M; Musca SC; Rieu I; Vidal T; Chambres P; Auxiette C; Dalens H; Marie Coulangeon L; Jalenques I; Lemaire JJ; Ulla M; Derost P; Marques A; Durif F
    Neuropsychologia; 2012 Oct; 50(12):2869-2879. PubMed ID: 22944002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STN-DBS does not change emotion recognition in advanced Parkinson's disease.
    Albuquerque L; Coelho M; Martins M; Guedes LC; Rosa MM; Ferreira JJ; Cattoni MB; Carvalho H; Ferreira AG; Martins IP
    Parkinsonism Relat Disord; 2014 Feb; 20(2):166-9. PubMed ID: 24182523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emotion recognition in Parkinson's disease after subthalamic deep brain stimulation: differential effects of microlesion and STN stimulation.
    Aiello M; Eleopra R; Lettieri C; Mondani M; D'Auria S; Belgrado E; Piani A; De Simone L; Rinaldo S; Rumiati RI
    Cortex; 2014 Feb; 51():35-45. PubMed ID: 24342106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fear recognition is impaired by subthalamic nucleus stimulation in Parkinson's disease.
    Biseul I; Sauleau P; Haegelen C; Trebon P; Drapier D; Raoul S; Drapier S; Lallement F; Rivier I; Lajat Y; Verin M
    Neuropsychologia; 2005; 43(7):1054-9. PubMed ID: 15769491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of emotional prosody is altered after subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Péron J; Grandjean D; Le Jeune F; Sauleau P; Haegelen C; Drapier D; Rouaud T; Drapier S; Vérin M
    Neuropsychologia; 2010 Mar; 48(4):1053-62. PubMed ID: 20005239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease.
    Alonso-Frech F; Zamarbide I; Alegre M; Rodríguez-Oroz MC; Guridi J; Manrique M; Valencia M; Artieda J; Obeso JA
    Brain; 2006 Jul; 129(Pt 7):1748-57. PubMed ID: 16684788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
    Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
    Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
    Lyons KE; Davis JT; Pahwa R
    Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic deep brain stimulation influences complex emotional musical experience in Parkinson's disease.
    Trost W; Leh F; Houvenaghel JF; Choppin S; Drapier S; Sauleau P; Haegelen C; Robert G; Grandjean D; Vérin M
    Neuropsychologia; 2018 Aug; 117():278-286. PubMed ID: 29936120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of levodopa and subthalamic stimulation on emotional conflict in Parkinson's disease.
    Martínez-Fernández R; Kibleur A; Chabardès S; Fraix V; Castrioto A; Lhommée E; Moro E; Lescoules L; Pelissier P; David O; Krack P
    Hum Brain Mapp; 2018 Dec; 39(12):5014-5027. PubMed ID: 30259598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of young onset Parkinson's disease after subthalamic stimulation--a cross-sectional study.
    Tsai ST; Hung HY; Hsieh TC; Lin SH; Lin SZ; Chen SY
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2082-7. PubMed ID: 23916724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.